{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:05:42Z","timestamp":1774566342807,"version":"3.50.1"},"reference-count":28,"publisher":"American Diabetes Association","issue":"3","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,3,1]]},"abstract":"<jats:p>OBJECTIVE\u2014The insulin resistance syndrome has been described as including hypertension. Previous studies have documented cross-sectional associations between insulin sensitivity (SI) and blood pressure or prevalent hypertension. Prospective data have been sparse.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014The Insulin Resistance Atherosclerosis Study (IRAS) is a prospective study of the associations of SI with atherosclerosis and other risk factors for cardiovascular disease. We examined the association between SI, measured using the frequently sampled intravenous glucose tolerance test with minimal model analysis, and incident hypertension (defined as per the Joint National Committee), at the 5-year examination in 840 IRAS participants who were free of hypertension at the baseline examination.<\/jats:p>\n               <jats:p>RESULTS\u2014Adjusted for age, sex, ethnicity, and smoking status, for each unit greater SI, the risk of hypertension was 10% lower (95% CI 2\u201319, P &amp;lt; 0.05).<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014These findings, from a prospective study, support the presence of a modest protective association between greater SI and lower risk of hypertension. These findings support the contention that interventions that improve SI may be beneficial with respect to the development of hypertension and cardiovascular disease. This contention should be tested in randomized clinical trials.<\/jats:p>","DOI":"10.2337\/diacare.26.3.805","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T22:51:27Z","timestamp":1173135087000},"page":"805-809","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":78,"title":["Insulin Sensitivity and the Risk of Incident Hypertension"],"prefix":"10.2337","volume":"26","author":[{"suffix":"Jr","given":"David C.","family":"Goff","sequence":"first","affiliation":[{"name":"Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina"},{"name":"Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Zaccaro","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Haffner","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed F.","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California at Los Angeles, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031220315020800_R1","doi-asserted-by":"crossref","unstructured":"Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes\u200837: 1595\u20131607, 1988","DOI":"10.2337\/diabetes.37.12.1595"},{"key":"2022031220315020800_R2","doi-asserted-by":"crossref","unstructured":"Haffner SM: Insulin and blood pressure: fact or fantasy? J Clin Endocrinol Metab\u200876:541\u2013543, 1993","DOI":"10.1210\/jcem.76.3.8445008"},{"key":"2022031220315020800_R3","doi-asserted-by":"crossref","unstructured":"Haffner SM: Epidemiology of hypertension and insulin resistance syndrome. J Hypertens\u2008(Suppl. 15):S25\u2013S30, 1997","DOI":"10.1097\/00004872-199715011-00003"},{"key":"2022031220315020800_R4","unstructured":"Reaven GM: Insulin resistance may or may not play a role in blood pressure regulation. J Intern Med\u2008242:407\u2013412, 1997"},{"key":"2022031220315020800_R5","doi-asserted-by":"crossref","unstructured":"Suzuki M, Kimura Y, Tsushima M, Harano Y: Association of insulin resistance with salt sensitivity and nocturnal fall of blood pressure. Hypertension\u20085:864\u2013868, 2000","DOI":"10.1161\/01.HYP.35.4.864"},{"key":"2022031220315020800_R6","doi-asserted-by":"crossref","unstructured":"Brett SE, Ritter JM, Chowienczyk PJ: Diastolic blood pressure changes during exercise positively correlate with serum cholesterol and insulin resistance. Circulation\u2008101:611\u2013615, 2000","DOI":"10.1161\/01.CIR.101.6.611"},{"key":"2022031220315020800_R7","doi-asserted-by":"crossref","unstructured":"Phillips RA, Krakoff LR, Dunaif A, Finegood DT, Gorlin R, Shimabukuro S: Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. J Clin Endocrin Metab\u200883:4284\u20134288, 1998","DOI":"10.1210\/jc.83.12.4284"},{"key":"2022031220315020800_R8","doi-asserted-by":"crossref","unstructured":"Heise T, Magnusson K, Heinemann L, Sawicki PT: Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension\u200832:243\u2013248, 1998","DOI":"10.1161\/01.HYP.32.2.243"},{"key":"2022031220315020800_R9","doi-asserted-by":"crossref","unstructured":"Toft I, Bonaa KH, Jenssen T: Insulin resistance in hypertension is associated with body fat rather than blood pressure. Hypertension\u200832:115\u2013122, 1998","DOI":"10.1161\/01.HYP.32.1.115"},{"key":"2022031220315020800_R10","doi-asserted-by":"crossref","unstructured":"Cabezas-Cerrato J, Garcia-Estevez DA, Araujo-Vilar D: Lack of association between both insulin resistance and plasma insulin levels with blood pressure values in essential hypertension. Horm Metab Res\u200829:561\u2013565, 1997","DOI":"10.1055\/s-2007-979101"},{"key":"2022031220315020800_R11","doi-asserted-by":"crossref","unstructured":"Wagenknecht LE, Mayer EJ, Rewers M, Haffner S, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, et al: The Insulin Resistance Atherosclerosis Study (IRAS) objectives, design, and recruitment results. Ann Epidemiol\u20085:464\u2013471, 1995","DOI":"10.1016\/1047-2797(95)00062-3"},{"key":"2022031220315020800_R12","doi-asserted-by":"crossref","unstructured":"Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, Murphy JR, Lezotte DC: Methods and prevalence of non-insulin dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am J Epidemiol\u2008129:295\u2013311, 1989","DOI":"10.1093\/oxfordjournals.aje.a115134"},{"key":"2022031220315020800_R13","doi-asserted-by":"crossref","unstructured":"Stern MP, Rosenthal M, Haffner SM, et al: Sex differences in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol\u2008120:834\u2013851, 1984","DOI":"10.1093\/oxfordjournals.aje.a113956"},{"key":"2022031220315020800_R14","doi-asserted-by":"crossref","unstructured":"Haffner SM, D\u2019Agostino R, Saad MF, Rewers M, Mykkanen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, Bergman RN: Increased insulin resistance and insulin secretion in nondiabetic African Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes\u200845:742\u2013748, 1996","DOI":"10.2337\/diabetes.45.6.742"},{"key":"2022031220315020800_R15","unstructured":"World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech Rep Ser., no. 727)"},{"key":"2022031220315020800_R16","doi-asserted-by":"crossref","unstructured":"Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YDI, Sands RE, Pei D, Savage PJ, Bergman RN: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes\u200843:1114\u20131121, 1994","DOI":"10.2337\/diab.43.9.1114"},{"key":"2022031220315020800_R17","unstructured":"Rothman KJ, Greenland S: Precision and Validity in Epidemiologic Studies. In Modern Epidemiology. Philadephia, PA, Lippincott-Raven, 1998 p. 123"},{"key":"2022031220315020800_R18","doi-asserted-by":"crossref","unstructured":"Greenland S, Neutra R: Control of confounding in the assessment of medical technology. Inter J Epidemiol\u20089:361\u2013367, 1980","DOI":"10.1093\/ije\/9.4.361"},{"key":"2022031220315020800_R19","doi-asserted-by":"crossref","unstructured":"Liese AD, Mayer-Davis EJ, Chambless LE, Folsom AR, Sharrett AR, Brancati FL, Heiss G: Elevated fasting insulin predicts incident hypertension: the ARIC study. J Hyperten\u200817:1169\u20131177, 1999","DOI":"10.1097\/00004872-199917080-00017"},{"key":"2022031220315020800_R20","doi-asserted-by":"crossref","unstructured":"Dyer AR, Liu K, Walsh M, Kiefe C, Jacobs DR Jr., Bild DE: Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study: Coronary Artery Risk Development in (Young) Adults. J Human Hyperten\u200813:13\u201321, 1999","DOI":"10.1038\/sj.jhh.1000740"},{"key":"2022031220315020800_R21","doi-asserted-by":"crossref","unstructured":"Salonen JT, Lakka TA, Valkonen VP, Everson SA, Kaplan GA: Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes\u200847:270\u2013275, 1998","DOI":"10.2337\/diab.47.2.270"},{"key":"2022031220315020800_R22","doi-asserted-by":"crossref","unstructured":"Shetterly SM, Rewers M, Hamman RF, Marshall JA: Patterns and predictors of hypertension incidence among Hispanics and non-Hispanic whites: the San Luis Valley Diabetes Study. J Hyperten\u200812:1095\u20131102, 1994","DOI":"10.1097\/00004872-199409000-00016"},{"key":"2022031220315020800_R23","doi-asserted-by":"crossref","unstructured":"Haffner SM, Mitchell BD, Valdez RA, Hazuda HP, Morales PA, Stern MP: Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Hyperten\u20085:147\u2013153, 1992","DOI":"10.1093\/ajh\/5.3.147"},{"key":"2022031220315020800_R24","unstructured":"Kelly GS: Insulin resistance: lifestyle and nutritional interventions. Alternative Med Rev\u20085:109\u2013132, 2000"},{"key":"2022031220315020800_R25","doi-asserted-by":"crossref","unstructured":"Granberry MC, Fonseca VA: Insulin resistance syndrome: options for treatment. Southern Med J\u200892:2\u201315, 1999","DOI":"10.1097\/00007611-199901000-00002"},{"key":"2022031220315020800_R26","doi-asserted-by":"crossref","unstructured":"Lithell HO: Insulin resistance and diabetes in the context of treatment of hypertension. Blood Pres\u2008(Suppl. 3):28\u201331, 1998","DOI":"10.1080\/080370598438456"},{"key":"2022031220315020800_R27","doi-asserted-by":"crossref","unstructured":"The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med\u2008342:145\u2013153, 2000","DOI":"10.1056\/NEJM200001203420301"},{"key":"2022031220315020800_R28","doi-asserted-by":"crossref","unstructured":"Heart Outcomes Prevention Evaluation (HOPE) Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet\u2008355:253\u2013259, 2000","DOI":"10.1016\/S0140-6736(99)12323-7"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/26\/3\/805\/665596\/dc0303000805.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/26\/3\/805\/665596\/dc0303000805.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T22:33:40Z","timestamp":1647124420000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/26\/3\/805\/29196\/Insulin-Sensitivity-and-the-Risk-of-Incident"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.26.3.805","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,1]]}}}